LOVAZA - 0173-0783-02 - (omega-3-acid ethyl esters)

Alphabetical Index


Drug Information of LOVAZA

Product NDC: 0173-0783
Proprietary Name: LOVAZA
Non Proprietary Name: omega-3-acid ethyl esters
Active Ingredient(s): 900    mg/1 & nbsp;   omega-3-acid ethyl esters
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, LIQUID FILLED
Coding System: National Drug Codes(NDC)

Labeler Information of LOVAZA

Product NDC: 0173-0783
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021654
Marketing Category: NDA
Start Marketing Date: 20081021

Package Information of LOVAZA

Package NDC: 0173-0783-02
Package Description: 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (0173-0783-02)

NDC Information of LOVAZA

NDC Code 0173-0783-02
Proprietary Name LOVAZA
Package Description 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (0173-0783-02)
Product NDC 0173-0783
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name omega-3-acid ethyl esters
Dosage Form Name CAPSULE, LIQUID FILLED
Route Name ORAL
Start Marketing Date 20081021
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name OMEGA-3-ACID ETHYL ESTERS
Strength Number 900
Strength Unit mg/1
Pharmaceutical Classes Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC]

Complete Information of LOVAZA


General Information